These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4599465)

  • 41. Clinical use of rabbit antihuman lymphocyte globulin in cadaver-kidney transplantation.
    Mannick JA; Davis RC; Cooperband SR; Glasgow AH; Williams LF; Harrington JT; Cavallo T; Schmitt GW; Idelson BA; Olsson CA; Nabseth DC
    N Engl J Med; 1971 May; 284(20):1109-15. PubMed ID: 4928659
    [No Abstract]   [Full Text] [Related]  

  • 42. Local graft irradiation as an adjunct to pharmacologic immunosuppression.
    Foster RS
    J Surg Res; 1974 May; 16(5):457-62. PubMed ID: 4598670
    [No Abstract]   [Full Text] [Related]  

  • 43. Survey of the current status of the clinical uses of antilymphocyte serum.
    Monaco AP; Codish SD
    Surg Gynecol Obstet; 1976 Mar; 142(3):417-26. PubMed ID: 766248
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
    Sutherland DE; Fryd DS; Strand MH; Canafax DM; Ascher NL; Payne WD; Simmons RL; Najarian JS
    Am J Kidney Dis; 1985 Jun; 5(6):318-27. PubMed ID: 3893106
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cyclophosphamide and human organ transplantation.
    Starzl TE; Halgrimson CG; Penn I; Martineau G; Schroter G; Amemiya H; Putnam CW; Groth CG
    Lancet; 1971 Jul; 2(7715):70-4. PubMed ID: 4103984
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunologic monitoring parameters in ALG- versus non-ALG-treated renal transplant patients.
    McAlack RF; Stern S; Beizer R; Sklar L; Bannett A
    Transplant Proc; 1979 Jun; 11(2):1431-2. PubMed ID: 382532
    [No Abstract]   [Full Text] [Related]  

  • 47. Reversal of acute clinical and experimental organ rejection using large doses of intravenous prednisolone.
    Bell PR; Briggs JD; Calman KC; Paton AM; Wood RF; Macpherson SG; Kyle K
    Lancet; 1971 May; 1(7705):876-80. PubMed ID: 4102025
    [No Abstract]   [Full Text] [Related]  

  • 48. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
    Sommer BG; Henry ML; Ferguson RM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1879-80. PubMed ID: 3274445
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of early administration of donor bone marrow cells on renal allograft survival in dogs treated with antilymphocyte serum and cyclosporine.
    Hartner WC; Markees TG; De Fazio SR; Shaffer D; Van Der Werf WJ; Gilchrist B; Yatko C; Monaco AP; Gozzo JJ
    Transplantation; 1995 Jan; 59(1):131-4. PubMed ID: 7839413
    [No Abstract]   [Full Text] [Related]  

  • 50. Mechanisms of immunosuppression by antilymphocyte antibody.
    Taub RN
    Pathobiol Annu; 1972; 2():129-51. PubMed ID: 4149315
    [No Abstract]   [Full Text] [Related]  

  • 51. Allogenic grafts of the heart in dogs treated with an anti-dog lymphocyte serum or globulin.
    Cachera JP; Lacombe M; Bui-Mong-Huang ; Lacassagne JP; Crepin Y; Hattaway A
    Eur Surg Res; 1969; 1(1):26-36. PubMed ID: 4107484
    [No Abstract]   [Full Text] [Related]  

  • 52. Discrepancy between PHA responsiveness and quantitative estimates of T-cell numbers in human peripheral blood during chronic renal failure and immunosuppression after transplantation.
    Lopez C; Simmons RL; Touraine JL; Park BH; Kiszkiss DF; Najarian JS; Good RA
    Clin Immunol Immunopathol; 1975 May; 4(1):135-42. PubMed ID: 1092496
    [No Abstract]   [Full Text] [Related]  

  • 53. Prediction of long term combined imuran ALG dosage.
    Ollodart RM; Flotte CT; Lubash GD; Young JD; Sadler JH; Ramos E
    Proc Clin Dial Transplant Forum; 1972; 2():8-16. PubMed ID: 4219814
    [No Abstract]   [Full Text] [Related]  

  • 54. Combined immunosuppression for canine renal allograft prolongation: antilymphocyte serum plus prednisolone or azathioprine.
    Weil R; Simmons RL
    Ann Surg; 1968 Feb; 167(2):239-45. PubMed ID: 4866845
    [No Abstract]   [Full Text] [Related]  

  • 55. Evaluation of intravenous route for administration of antilymphocyte globulins in humans.
    Traeger J; Touraine JL; Fries D; Berthoux F
    Transplant Proc; 1971 Mar; 3(1):749-53. PubMed ID: 4937966
    [No Abstract]   [Full Text] [Related]  

  • 56. Antithymocyte globulin in renal transplant krecipients. A clinical trial.
    Turcotte JG; Feduska NJ; Haines RF; Freier DT; Gikas PW; McDonald FD; Johnson AG; Morrell RM; Thompson NW
    Arch Surg; 1973 Apr; 106(4):484-8. PubMed ID: 4572345
    [No Abstract]   [Full Text] [Related]  

  • 57. Leukopenia and azathioprine management in renal homotransplantation.
    Haesslein HC; Pierce JC; Lee HM; Hume DM
    Surgery; 1972 Apr; 71(4):598-604. PubMed ID: 4553659
    [No Abstract]   [Full Text] [Related]  

  • 58. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
    Guttmann RD; Flemming C
    Clin Transplant; 1997 Jun; 11(3):185-92. PubMed ID: 9193840
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antithymocyte antisera globulin effect on human lymphoid neoplasia.
    Pirofsky B; Beaulieu R; Goldman RD
    Arch Intern Med; 1973 Aug; 132(2):171-4. PubMed ID: 4198179
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical experience with antilymphocyte globulin (ALG) in renal transplantation.
    Deodhar SD; Konomi K; Nakamoto S; Kuruvila KC
    Transplant Proc; 1971 Mar; 3(1):758-61. PubMed ID: 4937968
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.